Single-source supply dependence
A majority of key antibodies and some instrument components come from single suppliers, creating shortage risk.
- Scope
- NULISA assay antibodies and instrument/consumable components
- Materiality
- high
Alamar Biosciences, Inc. develops and commercializes proteomics and immunoassay instruments, consumables, and related services for life-science research. Its core platform includes the ARGO HT instrument, NULISA assay consumables, and TAP services, with sales primarily in North America, Europe, and Asia through direct and distribution channels.
| % | |
|---|---|
| Instruments | 45% Benchtop analytical instruments used for proteomics and immunoassay workflows. |
| Consumables | 40% Assay consumables and kits used on installed instruments for recurring testing. |
| Services | 15% TAP Services, analytical testing, and maintenance/repair contracts. |
Customers are primarily academic and research institutions, biopharmaceutical companies, contract research...
Universities and research centers buy instruments, consumables, and TAP Services for basic and translational research.
Drug developers use the platform for biomarker discovery, assay validation, and preclinical research.
CROs purchase services and systems to support outsourced analytical programs for pharma and biotech clients.
Labs buy instruments and consumables to offer testing and analytical services to third parties.
Channel partners resell products in selected international markets where direct coverage is limited.
Alamar sells primarily through direct channels in North America, Europe, and China, with additional distribution...
The company is expanding its installed base by broadening sales coverage, adding new instruments, and improving the...
A larger installed base increases recurring consumables demand and service revenue.
More applications and improved performance support adoption and customer retention.
Future regulated products could expand the addressable market beyond RUO research use.
The business depends on a small number of specialized suppliers and on customer funding cycles, so supply interruptions...
A majority of key antibodies and some instrument components come from single suppliers, creating shortage risk.
If products are viewed as clinical diagnostics, marketing authorization could be required before sale.
Many customers rely on government grants and year-end budgets, which can shift purchase timing.
A portion of revenue is denominated in euros and other foreign currencies, affecting reported results.
Tariffs, shipping delays, and labor shortages can disrupt supply and customer delivery.
: 11/08/2026